Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients – focus on esomeprazole

References

• PilottoAFranceschiMMaggiSAddanteFSancarloDOptimal management of peptic ulcer disease in the elderlyDrugs Aging201027754555820583849
   PubMed Web of Science ®Google Scholar
• RichterJEGastroesophageal reflux disease in the older patient: presentation, treatment, and complicationsAm J Gastroenterol200095236837310685737
   PubMed Web of Science ®Google Scholar
• MalfertheinerPChanFKMcCollKEPeptic ulcer diseaseLancet200937496991449146119683340
   PubMed Web of Science ®Google Scholar
• PilottoAHelicobacter pylori-associated peptic ulcer disease in older patients: current management strategiesDrugs Aging200118748749411482742
   PubMed Web of Science ®Google Scholar
• LauJYSungJHillCHendersonCHowdenCWMetzDCSystematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortalityDigestion201184210211321494041
   PubMed Web of Science ®Google Scholar
• ChristensenSRiisANørgaardMSørensenHTThomsenRWShort-term mortality after perforated or bleeding peptic ulcer among elderly patients: a population-based cohort studyBMC Geriatr200771817222340
   PubMedGoogle Scholar
• TahaASAngersonWJPrasadRMcCloskeyCGilmourDMorranCGClinical trial: the incidence and early mortality after peptic ulcer perforation, and the use of low-dose aspirin and nonsteroidal anti-inflammatory drugsAliment Pharmacol Ther200828787888518644010
   PubMed Web of Science ®Google Scholar
• ThomsenRWRiisAChristensenSNørgaardMSørensenHTDiabetes and 30-day mortality from peptic ulcer bleeding and perforation: a Danish population-based cohort studyDiabetes Care200629480581016567819
   PubMed Web of Science ®Google Scholar
• SungJJTsoiKKMaTKYungMYLauJYChiuPWCauses of mortality in patients with peptic ulcer bleeding: a prospective cohort study of 10,428 casesAm J Gastroenterol20101051848919755976
   PubMed Web of Science ®Google Scholar
• ZulloAHassanCCampoSMMoriniSBleeding peptic ulcer in the elderly: risk factors and prevention strategiesDrugs Aging2007241081582817896831
   PubMed Web of Science ®Google Scholar
• HungLCChingJYSungJJLong-term outcome of Helicobacter pylori-negative idiopathic bleeding ulcers: a prospective cohort studyGastroenterology200512871845185015940620
   PubMed Web of Science ®Google Scholar
• HiltonDImanNBurkeGJAbsence of abdominal pain in older persons with endoscopic ulcers: a prospective studyAm J Gastroenterol200196238038411232679
   PubMed Web of Science ®Google Scholar
• WangJKWangRTMeta-analysis on the epidemiology of Helicobacter pylori infection in ChinaZonghua Liu Xing Bing Xue Za Zhi2003246443446 Chinese
   Google Scholar
• LiZZouDMaXEpidemiology of peptic ulcer disease: endoscopic results of the systematic investigation of gastrointestinal disease in ChinaAm J Gastroenterol2010105122570257720736940
   PubMed Web of Science ®Google Scholar
• WolosinJDGertlerSLPetersonWLSandersfeldMAIsenbergJIGastric ulcer recurrence: follow-up of a double-blind, placebo-controlled trialJ Clin Gastroenterol198911112162646357
   PubMed Web of Science ®Google Scholar
• MalfertheinerPMegraudFO’MorainCCurrent concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus ReportGut200756677278117170018
   PubMed Web of Science ®Google Scholar
• CheyWDWongBCPractice Parameters Committee of the American College of GastroenterologyAmerican College of Gastroenterology guideline on the management of Helicobacter pylori infectionAm J Gastroenterol200710281808182517608775
   PubMed Web of Science ®Google Scholar
• KatelarisPHForbesGMTalleyNJCrottyBA randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE studyGastroenterology200212361763176912454831
   PubMed Web of Science ®Google Scholar
• GenéECalvetXAzagraRGisbertJPTriple vs quadruple therapy for treating Helicobacter pylori infection: a meta-analysisAliment Pharmacol Ther20031791137114312752350
   PubMed Web of Science ®Google Scholar
• CalvetXGarcíaNLópezTGisbertJPGenéERoqueMA meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infectionAliment Pharmacol Ther200014560360910792124
   PubMed Web of Science ®Google Scholar
• FuccioLMinardiMEZagariRMGrilliDMagriniNBazzoliFMeta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradicationAnn Intern Med2007147855356217938394
   PubMed Web of Science ®Google Scholar
• TankovicJLamarqueDLascolsCSoussyCJDelchierJCImpact of Helicobacter pylori resistance to clarithromycin on the efficacy of the omeprazole-amoxicillin-clarithromycin therapyAliment Pharmacol Ther200115570771311328266
   PubMed Web of Science ®Google Scholar
• MegraudFLamouliatteHReview article: the treatment of refractory Helicobacter pylori infectionAliment Pharmacol Ther200317111333134312786627
   PubMed Web of Science ®Google Scholar
• WuDCHsuPIWuJYSequential and concomitant therapy with 4 drugs are equally effective for eradication of H pylori infectionClin Gastroenterol Hepatol2010813641. e119804842
   PubMed Web of Science ®Google Scholar
• MalfertheinerPMegraudFO’MorainCAEuropean Helicobacter Study GroupManagement of Helicobacter pylori infection – the Maastricht IV/Florence Consensus ReportGut201261564666422491499
   PubMed Web of Science ®Google Scholar
• SilversteinFEFaichGGoldsteinJLGastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety StudyJAMA2000284101247125510979111
   PubMed Web of Science ®Google Scholar
• LanzaFLChanFKQuigleyEMPractice Parameters Committee of the American College of GastroenterologyGuidelines for prevention of NSAID-related ulcer complicationsAm J Gastroenterol2009104372873819240698
   PubMed Web of Science ®Google Scholar
• GriffinMRPiperJMDaughertyJRSnowdenMRayWANonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly personsAnn Intern Med199111442572631987872
   PubMed Web of Science ®Google Scholar
• ChanFKToKFWuJCEradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with nonsteroidal anti-inflammatory drugs: a randomized trialLancet2002359930091311809180
   PubMed Web of Science ®Google Scholar
• RostomADubeCWellsGPrevention of NSAID-induced gastroduodenal ulcersCochrane Database Syst Rev20024CD00229612519573
   PubMedGoogle Scholar
• LeontiadisGISreedharanADorwardSSystematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleedingHealth Technol Assess20071151iiiiv 1–16418021578
   PubMed Web of Science ®Google Scholar
• RostomAMuirKDubéCGastrointestinal safety of cyclooxygenase-2 inhibitors:a Cochrane Collaboration systematic reviewClin Gastroenterol Hepatol200757818828828.e117556027
   PubMed Web of Science ®Google Scholar
• KearneyPMBaigentCGodwinJHallsHEmbersonJRPatronoCDo selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomized trialsBMJ200633275531302130816740558
   PubMed Web of Science ®Google Scholar
• McGettiganPHenryDCardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2JAMA2006296131633164416968831
   PubMed Web of Science ®Google Scholar
• LanasAFuentesJBenitoRSerranoPBajadorESáinzRHelicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirinAliment Pharmacol Ther200216477978611929396
   PubMed Web of Science ®Google Scholar
• MalfertheinerPChanFKMcCollKEPeptic ulcer diseaseLancet200937496991449146119683340
   PubMed Web of Science ®Google Scholar
• MoukarbelGVSignorovitchJEPfefferMAGastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT TrialEur Heart J200930182226223219556260
   PubMed Web of Science ®Google Scholar
• ChanFKChungSCSuenBYPreventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxenN Engl J Med20013441396797311274623
   PubMed Web of Science ®Google Scholar
• ChanFKChingJYSuenBYTseYKWuJCSungJJEffects of Helicobacter pylori infection on long-term risk of peptic ulcer bleeding in low-dose aspirin usersGastroenterology2013144352853523333655
   PubMed Web of Science ®Google Scholar
• ChanFKChingJYHungLCClopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleedingN Engl J Med2005352323824415659723
   PubMed Web of Science ®Google Scholar
• LaiKCChuKMHuiWMEsomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complicationsClin Gastroenterol Hepatol20064786086516797240
   PubMed Web of Science ®Google Scholar
• BhattDLScheimanJAbrahamNSAmerican College of Cardiology Foundation Task Force on Clinical Expert Consensus DocumentsACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus DocumentsJ Am Coll Cardiol200852181502151719017521
   PubMed Web of Science ®Google Scholar
• YusufSZhaoFMehtaSRChrolaviciusSTognoniGFoxKKClopidogrel in Unstable Angina to Prevent Recurrent Events Trial InvestigatorsEffects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevationN Engl J Med2001345749450211519503
   PubMed Web of Science ®Google Scholar
• ConnollySJPogueJHartRGACTIVE InvestigatorsEffect of clopidogrel added to aspirin in patients with atrial fibrillationN Engl J Med2009360202066207819336502
   PubMed Web of Science ®Google Scholar
• BhattDLCryerBLContantCFCOGENT InvestigatorsClopidogrel with or without omeprazole in coronary artery diseaseN Engl J Med2010363201909191720925534
   PubMed Web of Science ®Google Scholar
• GilardMArnaudBCornilyJCInfluence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin:the randomized, double-blind OCLA (Omeprazole Clopidogrel Aspirin) studyJ Am Coll Cardiol200851325626018206732
   PubMed Web of Science ®Google Scholar
• LiXQAnderssonTBAhlströmMWeidolfLComparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activitiesDrug Metab. Dispos200432882182715258107
   PubMed Web of Science ®Google Scholar
• JuurlinkDNGomesTKoDTA population-based study of the drug interaction between proton pump inhibitors and clopidogrelCMAJ2009180771371819176635
   PubMed Web of Science ®Google Scholar
• KwokCSLokeYKMeta-analysis: the effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrelAliment Pharmacol Ther201031881082320102352
   PubMed Web of Science ®Google Scholar
• BeckerRCScheimanJDauermanHLAmerican College of Cardiology; American College of GastroenterologyManagement of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal proceduresJ Am Coll Cardiol200954242261227619942393
   PubMed Web of Science ®Google Scholar
• ChanFKAnti-platelet therapy and managing ulcer riskJ Gastroenterol Hepatol201227219519922142030
   PubMed Web of Science ®Google Scholar
• CiociolaAAMcSorleyDJTurnerKSykesDPalmerJBHelicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimatedAm J Gastroenterol19999471834184010406244
   PubMed Web of Science ®Google Scholar
• WongGLWongVWChanYHigh incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcersGastroenterology2009137252553119445937
   PubMed Web of Science ®Google Scholar
• WongGLAuKWLoAOGastroprotective therapy does not improve outcomes of patients with Helicobacter pylori-negative idiopathic bleeding ulcersClin Gastroenterol Hepatol201210101124112922732269
   PubMed Web of Science ®Google Scholar
• VakilNvan ZantenSVKahrilasPDentJJonesRGlobal Consensus GroupThe Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensusAm J Gastroenterol200610181900192016928254
   PubMed Web of Science ®Google Scholar
• WuJCGastroesophageal reflux disease: an Asian perspectiveJ Gastroenterol Hepatol200823121785179319120871
   PubMed Web of Science ®Google Scholar
• DentJEl-SeragHBWallanderMAJohanssonSEpidemiology of gastro-oesophageal reflux disease: a systematic reviewGut200554571071715831922
   PubMed Web of Science ®Google Scholar
• KangJYSystematic review: geographical and ethnic differences in gastro-oesophaeal reflux diseaseAliment Pharmacol Ther200420770571715379831
   PubMed Web of Science ®Google Scholar
• RäihäIJImpivaaraOSeppäläMSouranderLBPrevalence and characteristics of symptomatic gastroesophageal reflux in the elderlyJ Am Geriatr Soc19924012120912111447435
   PubMed Web of Science ®Google Scholar
• MoldJWReedLEDavisABAllenMLDecktorDLRobinsonMPrevalence of gastroesophageal reflux in the elderly patients in a primary care settingAm J Gastroenterol19918689659701858762
   PubMed Web of Science ®Google Scholar
• CollenMJAbdulianJDChenYKGastroesophageal reflux disease in the elderly: More severe disease that require aggressive therapyAm J Gastroenterol1995907105310577611195
   PubMed Web of Science ®Google Scholar
• el-SeragHBSonnenbergAAssociation between different forms of gastro-oesophageal reflux diseaseGut19974155945999414963
   PubMed Web of Science ®Google Scholar
• AmanoKAdachiKKatsubeTWatanabeMKinoshitaYRole of hiatus hernia and gastric mucosal atrophy in the development of reflux esophagitis in the elderlyJ Gastroenterol Hepatol200116213213611207891
   PubMed Web of Science ®Google Scholar
• CameronAJBarrett’s esophagus: prevalence and size of hiatal herniaAm J Gastroenterol19999482054205910445527
   PubMed Web of Science ®Google Scholar
• CorleyDAKuboABody mass index and gastroesophageal reflux disease: a systematic review and meta-analysisAm J Gastroenterol2006101112619262816952280
   PubMed Web of Science ®Google Scholar
• WuJCMuiLMCheungCMChanYSungJJObesity is associated with increased transient lower esophageal sphincter relaxationGastroenterology2007132388388917324403
   PubMed Web of Science ®Google Scholar
• HarumaKHamadaHMiharaMNegative association between Helicobacter pylori and reflux esophagitis in older patients: case-control study in JapanHelicobacter200051242910672048
   PubMed Web of Science ®Google Scholar
• WuJCSungJJNgEKPrevalence and distribution of Helicobacter pylori in gastroesophageal reflux disease:a study from the EastAm J Gastroenterol19999471790179410406236
   PubMed Web of Science ®Google Scholar
• O’ConnorHJReview article: Helicobacter pylori and gastro-oesophageal reflux disease-clinical implications and managementAliment Pharmacol Ther199913211712710102940
   PubMed Web of Science ®Google Scholar
• KoikeTOharaSSekineHIncreased gastric acid secretion after Helicobacter pylori eradication may be a factor for developing reflux esophagitisAliment Pharmacol Ther200115681382011380319
   PubMed Web of Science ®Google Scholar
• WuJCLaiACWongSKChanFKLeungWKSungJJDysfunction of oesophageal motility in Helicobacter pylori-infected patients with reflux esophagitisAliment Pharmacol Ther200115121913191911736722
   PubMed Web of Science ®Google Scholar
• FranceschiMDi MarioFLeandroGMaggiSPilottoAAcid-related disorders in the elderlyBest Pract Res Clin Gastroenterol200923683984819942162
   PubMed Web of Science ®Google Scholar
• RäihäIHietanenESouranderLSymptoms of gastro-oesophageal reflux disease in elderly patientsAge Ageing19912053653701755393
   PubMed Web of Science ®Google Scholar
• XiaHHLaiKCLamSKSymptomatic response to lansoprazole predicts abnormal acid reflux in endoscopy-negative patients with non-cardiac chest painAliment Pharmacol Ther200317336937712562449
   PubMed Web of Science ®Google Scholar
• SontagSThe medical management of reflux esophagitis. Role of antacids and acid inhibitionGastroenterol Clin North Am1990193673690
   Web of Science ®Google Scholar
• ShiSKlotzUProton pump inhibitors: an update of their clinical use and clinical pharmacokineticsEur J Clin Pharmacol2008641093595118679668
   PubMed Web of Science ®Google Scholar
• JohnsonDAReview of esomeprazole in the treatment of acid disordersExpert Opin Pharmacother20034225326412562316
   PubMed Web of Science ®Google Scholar
• AnderssonTRöhssKBredbergEHassan-AlinMPharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazoleAliment Pharmacol Ther200115101563156911563995
   PubMed Web of Science ®Google Scholar
• SostekMChenYAnderssonTEffect of timing of dosing in relation to food intake on the pharmacokinetics of esomeprazoleBr J Clin Pharmacol200764338639017425628
   PubMed Web of Science ®Google Scholar
• HasselgrenGHassan-AlinMAnderssonTClaar-NilssonCRöhssKPharmacokinetics study of esomeprazole in the elderlyClin Pharmacokinet200140214515011286324
   PubMed Web of Science ®Google Scholar
• CastellDOKahrilasPJRichterJEEsomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitisAm J Gastroenterol200297357558311922549
   PubMed Web of Science ®Google Scholar
• KahrilasPJFalkGWJohnsonDAEsomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trialAliment Pharmacol Ther200014101249125811012468
   PubMed Web of Science ®Google Scholar
• RichterJEKahrilasPJJohansonJEsomeprazole Study InvestigatorsEfficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trialAm J Gastroenterol200196365666511280530
   PubMed Web of Science ®Google Scholar
• FennertyMBJohansonJFHwangCSostekMEfficacy of esomeprazole 40 mg vs lansoprazole 30 mg for healing moderate to severe erosive oesophagitisAliment Pharmacol Ther200521445546315709997
   PubMed Web of Science ®Google Scholar
• GillessenABeilWModlinIMGatzGHoleU40 mg pantoprazole and 40 mg esomeprazole are equivalent in the healing of esophageal lesions and relief from gastroesophageal reflux disease-related symptomsJ Clin Gastroenterol200438433234015087692
   PubMed Web of Science ®Google Scholar
• HowdenCWBallardED2ndRobiesonWEvidence for therapeutic equivalence of lansoprazole 30 mg and esomeprazole 40 mg in the treatment of erosive oesophagitisClin Drug Investig200222299109
   PubMed Web of Science ®Google Scholar
• LabenzJArmstrongDLauritsenKExpo Study InvestigatorsA randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO studyAliment Pharmacol Ther200521673974615771760
   PubMed Web of Science ®Google Scholar
• LightdaleCJSchmittCHwangCHamelinBA multicenter, randomized, double-blind, 8-week comparative trial of low-dose esomeprazole (20 mg) and standard-dose omeprazole (20 mg) in patients with erosive esophagitisDig Dis Sci200651585285716773434
   PubMed Web of Science ®Google Scholar
• MatonPNVakilNBLevineJGEsomeprazole Study InvestigatorsSafety and efficacy of long-term esomeprazole therapy in patients with healed erosive oesophagitisDrug Saf200124862563511480494
   PubMed Web of Science ®Google Scholar
• DevaultKRJohansonJFJohnsonDALiuSSostekMBMaintenance of healed erosive esophagitis:a randomized six-month comparison of esomeprazole twenty milligrams with lansoprazole fifteen milligramsClin Gastroenterol Hepatol20064785285916682260
   PubMed Web of Science ®Google Scholar
• LauritsenKDevièreJBigardMAEsomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study resultsAliment Pharmacol Ther200317Suppl 124 discussion 25–2712614304
   PubMed Web of Science ®Google Scholar
• LabenzJArmstrongDLauritsenKEsomeprazole 20 mg vs pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO studyAliment Pharmacol Ther200522980381116225489
   PubMed Web of Science ®Google Scholar
• ArmstrongDTalleyNJLauritsenKThe role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazoleAliment Pharmacol Ther200420441342115298635
   PubMed Web of Science ®Google Scholar
• KatzPOCastellDOLevineDEsomeprazole resolves chronic heartburn in patients without erosive esophagitisAliment Pharmacol Ther200318987588214616151
   PubMed Web of Science ®Google Scholar
• PaceFToniniMPallottaSMolteniPPorroGBSystematic review: maintenance treatment of gastro-oesophageal reflux disease with proton pump inhibitors taken ‘on-demand’Aliment Pharmacol Ther200726219520417593065
   PubMed Web of Science ®Google Scholar
• LaineLReview article: esomeprazole in the treatment of Helicobacter pyloriAliment Pharmaco Ther200216Suppl 4115118
   Web of Science ®Google Scholar
• GoldsteinJLJohansonJFSuchowerLJBrownKAHealing of gastric ulcers with esomeprazole versus ranitidine in patients who continued to receive NSAID therapy: a randomized trialAm J Gastroenterol2005100122650265716393215
   PubMed Web of Science ®Google Scholar
• ScheimanJMYeomansNDTalleyNJPrevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitorsAm J Gastroenterol2006101470171016494585
   PubMed Web of Science ®Google Scholar
• ScheimanJMDevereauxPJHerlitzJPrevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON)Heart2011971079780221415072
   PubMed Web of Science ®Google Scholar
• SungJJBarkunAKuipersEJPeptic Ulcer Bleed Study GroupIntravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trialAnn Intern Med2009150745546419221370
   PubMed Web of Science ®Google Scholar
• ReckerRRCalcium absorption and achlorhydriaN Engl J Med1985313270734000241
   PubMed Web of Science ®Google Scholar
• MizunashiKFurukawaYKatanoKAbeKEffect of omeprazole, an inhibitor of H+, K(+)-ATPase, on bone resorption in humansCalcif Tissue Int199353121258102318
   PubMed Web of Science ®Google Scholar
• YangYXLewisJDEpsteinSMetzDCLong-term proton pump inhibitor therapy and risk of hip fractureJAMA2006296242947295317190895
   PubMed Web of Science ®Google Scholar
• YuEWBauerSRBainPABauerDCProton pump inhibitors and risk of fractures:a meta-analysis of 11 international studiesAm J Med2011124651952621605729
   PubMed Web of Science ®Google Scholar
• García RodríguezLARuigómezAPanésJUse of acid-suppressing drugs and the risk of bacterial gastroenteritisClin Gastroenterol Hepatol20075121418142318054750
   PubMed Web of Science ®Google Scholar
• DialSDelaneyJABarkunANSuissaSUse of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated diseaseJAMA2005294232989299516414946
   PubMed Web of Science ®Google Scholar
• LeonardJMarshallJKMoayyediPSystematic review of the risk of enteric infection in patients taking acid suppressionAm J Gastroenterol2007102920472056 quiz 205717509031
   PubMed Web of Science ®Google Scholar
• KwokCSArthurAKAnibuezeCISinghSCavallazziRLokeYKRisk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysisAm J Gastroenterol201210771011101922525304
   PubMed Web of Science ®Google Scholar
• JanarthananSDitahIAdlerDGEhrinpreisMNClostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysisAm J Gastroenterol201210771001101022710578
   PubMed Web of Science ®Google Scholar
• CampbellMSObsteinKReddyKRYangYXAssociation between proton pump inhibitor use and spontaneous bacterial peritonitisDig Dis Sci200853239439817616817
   PubMed Web of Science ®Google Scholar
• BajajJSZadvornovaYHeumanDMAssociation of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascitesAm J Gastroenterolol2009104511301134
   PubMed Web of Science ®Google Scholar
• TrikudanathanGIsraelJCappaJO’SullivanDMAssociation between proton pump inhibitors and spontaneous bacterial peritonitis in cirrhotic patients – a systematic review and meta-analysisInt J Clin Pract201165667467821564440
   PubMed Web of Science ®Google Scholar
• LaheijRJSturkenboomMCHassingRJDielemanJStrickerBHJansenJBRisk of community-acquired pneumonia and use of gastric acid-suppressive drugsJAMA2004292161955196015507580
   PubMed Web of Science ®Google Scholar
• GulmezSEHolmAFrederiksenHJensenTGPedersenCHallasJUse of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control studyArch Intern Med2007167995095517502537
   PubMedGoogle Scholar
• SarkarMHennessySYangYXProton-pump inhibitor use and the risk for community-acquired pneumoniaAnn Intern Med2008149639139818794558
   PubMed Web of Science ®Google Scholar
• JenaABSunEGoldmanDPConfounding in the association of proton pump inhibitor use with risk of community-acquired pneumoniaJ Gen Intern Med201328222323022956446
   PubMed Web of Science ®Google Scholar
• MarcuardSPAlbernazLKhazaniePGOmeprazole therapy causes malabsorption of cyanocobalamin (vitamin B12)Ann Intern Med199412032112158273984
   PubMed Web of Science ®Google Scholar
• ValuckRJRuscinJMA case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adultsJ Clin Epidemiol200457442242815135846
   PubMed Web of Science ®Google Scholar
• HirschowitzBIWorthingtonJMohnenJVitamin B12 deficiency in hypersecretors during long-term acid suppression with proton pump inhibitorsAliment Pharmacol Ther200827111110112118315582
   PubMed Web of Science ®Google Scholar
• EpsteinMMcGrathSLawFProton-pump inhibitors and hypomagnesemic hypoparathyroidismN Engl J Med2006355171834183617065651
   PubMed Web of Science ®Google Scholar
• CundyTDissanayakeASevere hypomagnesaemia in long-term users of proton-pump inhibitorsClin Endocrinol (Oxf)200869233834118221401
   PubMed Web of Science ®Google Scholar
• CentanniMGarganoLCanettieriGThyroxine in goiter, Helicobacter pylori infection, and chronic gastritisN Engl J Med2006354171787179516641395
   PubMed Web of Science ®Google Scholar
• KuipersEJLundellLKlinkenberg-KnolECAtrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplicationN Engl J Med199633416101810228598839
   PubMed Web of Science ®Google Scholar
• SungJJLinSRChingJYAtrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized studyGastroenterology2000119171410889149
   PubMed Web of Science ®Google Scholar
• FockKMTalleyNJFassRAsia–Pacific consensus on the management of gastroesophageal reflux disease: updateJ Gastroenterol Hepatol200823182218171339
   PubMed Web of Science ®Google Scholar
• FrelingerAL3rdLeeRDMulfordDJA randomized, 2-period, crossover design study to assess the effects of dexlansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteersJ Am Coll Cardiol201259141304131122464259
   PubMed Web of Science ®Google Scholar